Dr. Matt Kaeberlein is a Professor of Laboratory Medicine and Pathology at the University of Washington School of Medicine.  Dr. Kaeberlein’s research interests are focused on biological mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life. He has published more than 200 scientific papers and has been recognized by several prestigious awards including young investigator awards from the Ellison Medical Foundation and the Alzheimer’s Association, the Vincent Cristofalo Rising Start in Aging Research Award, the Murdock Trust Award,  the Kleemeier Award from the Gerontological Society of America (GSA), and the National Institute on Aging (NIA) Nathan W. Shock Award.  Dr. Kaeberlein has been awarded Fellow status with the American Association for the Advancement of Science (AAAS), the American Aging Association (AGE), and GSA.  He is currently the CEO and Chair of AGE and has served on the Board of Directors for the Federation of American Societies for Experimental Biology (FASEB) and AGE, and on Council for GSA. Dr. Kaeberlein is the founding Director of the University of Washington (UW) Healthy Aging and Longevity Research Institute, the Director of the NIH Nathan Shock Center of Excellence in the Basic Biology of Aging at UW, Director of the T32 Biological Mechanisms of Healthy Aging Training Program, and founder and co-Director of the Dog Aging Project.